Vericel Corp (NAS:VCEL)
$ 45.07 -1.16 (-2.51%) Market Cap: 2.30 Bil Enterprise Value: 2.25 Bil PE Ratio: 107.31 PB Ratio: 6.46 GF Score: 81/100

Q3 2025 Vericel Corp Earnings Call Transcript

Nov 6, 2025 / 01:30 PM GMT
Release Date Price: $38.75 (+4.17%)

Key Points

Positve
  • Vericel Corp (VCEL) reported record third-quarter total revenue of $67.5 million, exceeding guidance and driven by a 25% increase in Macy revenue.
  • The company achieved a GAAP net income of over $5 million and an adjusted EBITDA margin of 25% for the quarter.
  • Macy's third-quarter performance was bolstered by strong biopsy growth and the successful launch of Macy Arthro, with over 800 trained surgeons.
  • Vericel Corp (VCEL) generated record third-quarter operating cash flow of more than $22 million, nearly matching the previous year's fourth quarter.
  • The company is on track to initiate the phase 3 Macy ankle clinical study, representing a substantial growth opportunity and potential expansion into other orthopedic markets.
Negative
  • Despite strong performance, Vericel Corp (VCEL) remains cautious about providing specific 2026 guidance, indicating potential uncertainties in future projections.
  • The company faces variability in burn care revenue, with ESL trends similar to the previous year's fourth quarter, suggesting potential challenges in maintaining consistent growth.
  • There is no assumption of additional NexArid revenue related to the BARTA RFP process, indicating potential limitations in revenue growth from this segment.
  • The company anticipates increased operating expenses in the fourth quarter, including investments related to salesforce expansion and the ankle trial ramp-up.
  • Vericel Corp (VCEL) acknowledges potential variability in fourth-quarter performance due to the largest quarter size and year-end holidays, which could impact revenue consistency.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

VCEL.OQ - Vericel Corp
Q3 2025 Vericel Corp Earnings Call
Nov 06, 2025 / 01:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to the Verisal Corporation 3rd quarter 2025 earnings call.

Today's conference is being recorded. At this time, I would like to turn the conference over to Eric Burns, Verisal's Vice President of Finance and Investor Relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and good morning everyone.

Joining me on today is called our Verisal's President and Chief Executive Officer, Dick Colangelo, and our Chief Financial Officer, Joe Mara.

Before we begin Let me remind you that on today's call, we will be
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot